Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: A phase I study

Gynecologic Oncology

Volumn 87, Issue 1, 2002, Pages 98-103

  Rein, D T ^a   Kurbacher, C M ^b   Breidenbach, M ^b   Schondorf T ^b   Schmidt, T ^b   Konig E ^b   Gohring U J ^b   Blohmer, J U ^c   Mallmann, P ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Carbo platin; Cervical cancer; Docetaxel; Neoadjuvant chemotherapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; CARBOPLATIN; DEXAMETHASONE; DOCETAXEL; METOCLOPRAMIDE; ONDANSETRON; TROPISETRON;

ADULT; ALOPECIA; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOPENIA; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; ONYCHOLYSIS; OUTPATIENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SENSORY NEUROPATHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; WORLD HEALTH ORGANIZATION;

EID: 0036919966     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6786     Document Type: Article

References (39)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. Cancer J Clin 1999;49:33-64.
2. Sardi JR, di Paola GR, Cachau A, et al. A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol 1986;25:139-49.
3. Friedlander ML, Atkinson K, Coppleson JV, et al. The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study. Gynecol Oncol 1984;19:1-7.
4. Sardi J, Giaroli A, Sananes C, et al. Randomised trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: An unexpected therapeutic management. Int J Gynecol Cancer 1996;6:85-93.
5. Park RC, Thigpen JT. Chemotherapy in advanced and recurrent cervical cancer. A review. Cancer 1993;71(Suppl. 4):1446-50.
6. Omura GA, Blessing JA, Vaccarello L, et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 1997;15:165-71.
7. Leborgne F, Leborgne JH, Doldan R, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and Phase III randomized trial. Int J Radiat Oncol Biol Phys 1997;37:343-50.
8. Tattersall MH, Lorvidhaya V, Vootiprux V, et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. J Clin Oncol 1995;13:444-51.
9. Sundfor K, Trope CG, Hogberg T, et al. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 1996;77:2371-8.
10. Eisenhauer EA, Vermorken JB. New drugs in gynecologic oncology. Curr Opin Oncol 1996;8:404-14.
11. Francis P, Schneider J, Hann L, et al. Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer. J Clin Oncol 1994;12:2301-8.
12. Fossella FV, Lee JS, Shin DM, et al. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. J Clin Oncol 1995;13:645-51.
13. Goodman SN, Zahurak ML, Piantadosi S. Some practical improvements in the continual reassessment method for Phase I studies. Stat Med 1995;15:1149-61.
14. Bonomi P, Blessing JA, Stehman FB, et al. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 1985;3:1079-85.
15. Thigpen JT, Blessing JA, DiSaia PJ, et al. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1989;32:198-202.
16. Lira-Puerto V, Silva A, Morris M, et al. Phase II trial of carboplatin or iproplatin in cervical cancer. Cancer Chemother Pharmacol 1991;28:391-6.
17. Thigpen T. Chemotherapy in the management of advanced or recurrent carcinoma of the cervix. In: Rubin SC and Hoskins WJ, editors. Cervical Cancer and Preinvasive Neoplasia. New York: Lippincott-Raven, 1996;331-42.
18. Rein DT, Kurbacher CM. The role of chemotherapy in invasive cancer of the cervix uteri: Current standards and future prospects. Anticancer Drugs 2001;12:787-95.
19. NIH Consensus Conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 1995;273:491-7.
20. Mangioni C, Bolis G, Pecorelli S, et al. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin. J Natl Cancer Inst 1989;81:1464-71.
21. Aoki Y, Tomita M, Sato T, et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol 2001;83:263-7.
22. Duenas-Gonzales A, Lopez-Graniel C, Gonzales A, et al. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Ann Oncol 2001;12:541-7.
23. Etcheverry MG, Marantz A, Saine M, et al. Neoadjuvant chemotherapy with cisplatin, ifosfamide, and 5-fluorouracil in the treatment of locally advanced cervical cancer. Int J Gynecol Cancer 2000;10:53-8.
24. D'Agostino G, Distefano M, Greggi S, et al. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, pacli-taxel and cisplatin. Cancer Chemother Pharmacol 2002;49:256-60.
25. Giannakakis T, Ziras N, Kakolyris S, et al. Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: A multicentre Phase I study. Eur J Cancer 2000;36:742-7.
26. Vasey PA, Atkinson R, Coleman R, et al. Dose-finding study of docetaxel-carboplatin in untreated advanced epithelial ovarian cancer (EOC). Ann Oncol 1989;9(Suppl. 4): abstract 66.
27. Belani CP, Hadeed V, Ramanathan R, et al. Docetaxel and carboplatin: A Phase I and pharmacokinetic trial of advanced nonhematologic malignancies. Proc Am Soc Clin Oncol 1997;16:220a (abstract 771).
28. Bunn PA Jr. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Semin Oncol 1996;23(Suppl. 16):18-25.
29. Macha HN, Gatzemeier U, Betticher DC, et al. Randomized multicenter trial comparing paclitaxel/carboplatin (CAR) versus paclitaxel/cisplatin (CIS) in advanced non-small cell lung cancer (NSCC): Results of a planned interim analysis. Proc Am Soc Clin Oncol 1998;17:465a (abstract 1789).
30. Porzio G, Ficorella C, Toro G, et al. Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. Tu-mori 2001;87:25-6.
31. Judson I, Kelland LR. New developments and approaches in the platinum arena. Drugs 2000;59:29-36.
32. Vigano L, Locatelli A, Graselli A, et al. Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy. Invest New Drugs 2001;19:179-96.
33. Piver MS, Ghamande SA, Eltabbakh GH, et al. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - A phase II study. Gynecol Oncol 1999;75:334-7.
34. Bloss JD, Lucci JA 3rd, DiSaia PJ, et al. A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix. Gynecol Oncol 1995;59:105-10.
35. Patton TJ Jr, Kavanagh JJ, Delclos L, et al. Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina. Gynecol Oncol 1991;42:54-59.
36. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma. N Engl J Med 1999;340:1154-61.
37. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
38. Morris M, Eifel PJ, Grigsby PW, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high risk cervical cancer. N Engl J Med 1999;340:1137-43.
39. Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.